Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 5
2003 9
2004 4
2005 5
2006 9
2007 17
2008 5
2009 7
2010 7
2011 7
2012 2
2013 10
2014 15
2015 18
2016 5
2017 7
2018 9
2019 11
2020 12
2021 12
2022 5
2023 12
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation.
Guo W, Strouse C, Mery D, Siegel ER, Munshi MN, Ashby TC, Cheng Y, Sun F, Wanchai V, Zhang Z, Bailey C, Alapat DV, Peng H, Al Hadidi S, Thanendrarajan S, Schinke C, Zangari M, van Rhee F, Tricot G, Shaughnessy JD Jr, Zhan F. Guo W, et al. Among authors: zhan f. Cancers (Basel). 2024 Mar 11;16(6):1116. doi: 10.3390/cancers16061116. Cancers (Basel). 2024. PMID: 38539451 Free PMC article.
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
Guo W, Zhan Y, Mery D, Siegel ER, Sun F, Cheng Y, Ashby TC, Zhang Z, Bailey C, Alapat DV, Peng H, Hadidi SA, Thanendrarajan S, Schinke C, Zangari M, van Rhee F, Tricot G, Shaughnessy JD, Zhan F. Guo W, et al. Among authors: zhan f. Blood Cancer J. 2024 Feb 14;14(1):30. doi: 10.1038/s41408-024-00998-9. Blood Cancer J. 2024. PMID: 38355688 Free PMC article. No abstract available.
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
Mao X, Yan W, Mery D, Liu J, Fan H, Xu J, Xu Y, Sui W, Deng S, Zou D, Du C, Yi S, van Rhee F, Barlogie B, Shaughnessy JD Jr, Anderson KC, Zhan F, Qiu L, An G. Mao X, et al. Among authors: zhan f. Am J Hematol. 2024 Apr;99(4):523-533. doi: 10.1002/ajh.27207. Epub 2024 Jan 21. Am J Hematol. 2024. PMID: 38247315
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.
Sun F, Cheng Y, Wanchai V, Guo W, Mery D, Xu H, Gai D, Siegel E, Bailey C, Ashby C, Al Hadidi S, Schinke C, Thanendrarajan S, Ma Y, Yi Q, Orlowski RZ, Zangari M, van Rhee F, Janz S, Bishop G, Tricot G, Shaughnessy JD Jr, Zhan F. Sun F, et al. Among authors: zhan f. Nat Commun. 2024 Jan 19;15(1):615. doi: 10.1038/s41467-024-44873-4. Nat Commun. 2024. PMID: 38242888 Free PMC article.
Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up.
Al Hadidi S, Ababneh OE, Schinke CD, Thanendrarajan S, Bailey C, Smith R, Panozzo S, Alapat D, Cottler-Fox M, Tricot G, Shaughnessy JD Jr, Zhan F, Sawyer J, Barlogie B, Zangari M, van Rhee F. Al Hadidi S, et al. Among authors: zhan f. Blood Adv. 2024 Feb 13;8(3):703-707. doi: 10.1182/bloodadvances.2023011601. Blood Adv. 2024. PMID: 38052037 Free PMC article.
Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients.
Strouse C, Mott SL, Smith BJ, Magalhaes-Silverman M, Farooq U, Zhan F, Jethava Y, Tricot G. Strouse C, et al. Among authors: zhan f. Bone Marrow Transplant. 2024 Jan;59(1):128-130. doi: 10.1038/s41409-023-02119-9. Epub 2023 Oct 10. Bone Marrow Transplant. 2024. PMID: 37816907 Free PMC article. No abstract available.
179 results